Difference between revisions of "C-cell hyperplasia"

Jump to navigation Jump to search
Line 34: Line 34:
==General==
==General==
*Screening for C-cell hyperplasia/[[medullary thyroid carcinoma]] done with ''serum calcitonin level''.<ref name=pmid19726541>{{cite journal |author=Machens A, Hoffmann F, Sekulla C, Dralle H |title=Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer |journal=Endocr. Relat. Cancer |volume=16 |issue=4 |pages=1291–8 |year=2009 |month=December |pmid=19726541 |doi=10.1677/ERC-09-0136 |url=http://erc.endocrinology-journals.org/cgi/content/full/16/4/1291}}</ref>
*Screening for C-cell hyperplasia/[[medullary thyroid carcinoma]] done with ''serum calcitonin level''.<ref name=pmid19726541>{{cite journal |author=Machens A, Hoffmann F, Sekulla C, Dralle H |title=Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer |journal=Endocr. Relat. Cancer |volume=16 |issue=4 |pages=1291–8 |year=2009 |month=December |pmid=19726541 |doi=10.1677/ERC-09-0136 |url=http://erc.endocrinology-journals.org/cgi/content/full/16/4/1291}}</ref>
*Associated with [[multiple endocrine neoplasia type 2A]].<ref name=pmid21134882>{{Cite journal  | last1 = Tyer | first1 = NM. | last2 = Braunstein | first2 = GD. | last3 = Frishberg | first3 = D. | title = Unusual case of multiple endocrine neoplasia type 2A syndrome without medullary thyroid carcinoma. | journal = Endocr Pract | volume = 17 | issue = 2 | pages = e4-7 | month =  | year =  | doi = 10.4158/EP10157.CR | PMID = 21134882 }}</ref>
 
**May be found in specimen of a surgery done to exclude [[medullary thyroid carcinoma|MTC]] in the context of [[MEN 2A]].<ref name=pmid18976013>{{Cite journal  | last1 = Etit | first1 = D. | last2 = Faquin | first2 = WC. | last3 = Gaz | first3 = R. | last4 = Randolph | first4 = G. | last5 = DeLellis | first5 = RA. | last6 = Pilch | first6 = BZ. | title = Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases. | journal = Arch Pathol Lab Med | volume = 132 | issue = 11 | pages = 1767-73 | month = Nov | year = 2008 | doi = 10.1043/1543-2165-132.11.1767 | PMID = 18976013 }}</ref>
Associated with:
*[[Multiple endocrine neoplasia type 2A]]<ref name=pmid21134882>{{Cite journal  | last1 = Tyer | first1 = NM. | last2 = Braunstein | first2 = GD. | last3 = Frishberg | first3 = D. | title = Unusual case of multiple endocrine neoplasia type 2A syndrome without medullary thyroid carcinoma. | journal = Endocr Pract | volume = 17 | issue = 2 | pages = e4-7 | month =  | year =  | doi = 10.4158/EP10157.CR | PMID = 21134882 }}</ref> - may be found in specimen of a surgery done to exclude [[medullary thyroid carcinoma|MTC]] in the context of [[MEN 2A]].<ref name=pmid18976013>{{Cite journal  | last1 = Etit | first1 = D. | last2 = Faquin | first2 = WC. | last3 = Gaz | first3 = R. | last4 = Randolph | first4 = G. | last5 = DeLellis | first5 = RA. | last6 = Pilch | first6 = BZ. | title = Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases. | journal = Arch Pathol Lab Med | volume = 132 | issue = 11 | pages = 1767-73 | month = Nov | year = 2008 | doi = 10.1043/1543-2165-132.11.1767 | PMID = 18976013 }}</ref>
*[[Multiple endocrine neoplasia type 2B]].<ref name=pmid20301434>{{Cite journal  | last1 = Pagon | first1 = RA. | last2 = Adam | first2 = MP. | last3 = Ardinger | first3 = HH. | last4 = Wallace | first4 = SE. | last5 = Amemiya | first5 = A. | last6 = Bean | first6 = LJH. | last7 = Bird | first7 = TD. | last8 = Fong | first8 = CT. | last9 = Mefford | first9 = HC. | title = Multiple Endocrine Neoplasia Type 2 | journal =  | volume =  | issue =  | pages =  | month =  | year =  | doi =  | PMID = 20301434 }}</ref>


==Gross==
==Gross==